Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
IDXX
TEVA
Add up to 3 more stocks
IDXX
IDEXX Laboratories, Inc.
+0.87%
$549.80+4.72Delayed quote: Aug 28, 2026, 12:50 PM EDT
Market Cap
$43.37B
52W Range
$518.55 - $769.98
TEVA
Teva Pharmaceutical Industries Limited
-2.70%
$36.60-1.01Delayed quote: Aug 28, 2026, 12:50 PM EDT
Market Cap
$42.63B
52W Range
$17.94 - $38.37
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 38.60 | 62.70 |
| Forward P/E | 36.90 | 18.80 |
| P/B Ratio | 27.27 | 5.73 |
| P/S Ratio | 9.66 | 2.57 |
| P/FCF Ratio | 35.16 | 32.96 |
| EV/EBITDA | 27.83 | 19.40 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 62.5% | 52.5% |
| Operating Margin | 32.0% | 11.4% |
| Net Margin | 25.0% | 4.1% |
| ROE | 70.7% | 9.1% |
| ROA | 33.1% | 1.8% |
| ROIC | 41.3% | 6.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.17 | 0.88 |
| Quick Ratio | 0.87 | 0.67 |
| Debt/Equity | 0.68 | 2.18 |
| Interest Coverage | 35.54 | 2.35 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.